metricas
covid
Buscar en
Medicina de Familia. SEMERGEN
Toda la web
Inicio Medicina de Familia. SEMERGEN Infiltraciones locales en atención primaria
Información de la revista
Vol. 27. Núm. 10.
Páginas 526-536 (Noviembre 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 27. Núm. 10.
Páginas 526-536 (Noviembre 2001)
Acceso a texto completo
Infiltraciones locales en atención primaria
Visitas
19244
J. García Santos*
Centro de Salud Moraleja de Enmedio. Madrid. Grupo de Traumatología en Atención Primaria (GTAP)
J.J. Rodríguez Alonso*
* Médico de familia. Centro de Salud Villaviciosa de Odón. Madrid. Grupo de Traumatología en Atención Primaria (GTAP)
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.L. Hollander, E.M. Brown, R.A. Jessar, C.Y. Brown.
Hydrocortisone and cortisone injected into arthritic joints comparative effects of and use of hydrocrtisone as a local antiarthritic agent.
JAMA, 147 (1951), pp. 1629-1635
[2.]
B.L. Stolzer, C.H. Eisenbeis, J.H. Barr, J.O. Crittenden, H.M. Margolis.
Intra-articular injections of adrenocorticosteroids in patients with arthritis.
Penn Med J, 65 (1962), pp. 911-914
[3.]
L.E. Hart.
Exercise and soft tissue injury.
Baillière's Clinical Rheumatology, 8 (1994), pp. 137-148
[4.]
M.A. Crespo, C. Martín.
Afecciones traumáticas del deporte en los niños. Lesiones por uso y esfuerzo excesivos.
Arch Med Deporte, 11 (1994), pp. 135-144
[5.]
W. Breit, M. Frosch, U. Meyer, A. Heinecke, G. Ganser.
A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis.
J Rheumatol, 27 (2000), pp. 2696-2702
[6.]
J.L. Hollander, R.A. Jessar, E.M. Brown.
Intra-synovial corticosteroid therapy: a decade of use.
Bull Rheum Dis, 11 (1961), pp. 239-240
[7.]
D. Barraclough.
The use of corticosteroid agents in connective tissue disorders.
Med J Aust, 144 (1986), pp. 427-432
[8.]
G.D. Groff, W.A. Franck, D.A. Raddatz.
Systemic steroid therapy for acute gout: a clinical trial and review of the literature.
Semin Arthritis Rheum, 19 (1990), pp. 329-336
[9.]
D.W. Roane, M.D. Harris, M.T. Carpenter, D.R. Finger, M.J. Jarek, J.A. Alloway, et al.
Prospective use of intramuscular triamcinolone acetonide in pseudogout.
J Rheumatol, (1997 Jun), pp. 1168-1170
[10.]
K. Gaffney, J. Ledingham, J.D. Perry.
Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response.
Ann Rheum Dis, 54 (1995), pp. 379-381
[11.]
E. Román Burillo, E. Fernández Yebra, S. Castellanos Redondo, M. Imaz Rubalcaba, A. Ruiz Sánchez, P. Burón Martínez.
Satisfacción de los pacientes tratados con infiltraciones locales en un EAP.
Aten Primaria, 8 (1996), pp. 367
[12.]
P.D. Fadale, M.E. Wiggins.
Corticosteroid injections: their use and abuse.
J Am Acad Orthop Surg, 2 (1994), pp. 133-140
[13.]
H. Hartmann.
Arthrocentesis in rheumatology practice.
Tidsskr Nor Laegeforen, 120 (2000), pp. 800-802
[14.]
P.R. Dahl, M.J. Zalla, R.K. Winkelman.
Localized involutional lipoatrophy: a clinicopathologic study of 16 patients.
J Am Acad Dermatol, 35 (1996), pp. 523-528
[15.]
O.E. Ijsselmuiden, K.J. Knegt-Junk, R.G. Van Wijk, T.H. Van Hoost.
Cutaneous adverse reactions after intra-articular injection of triamcinolone acetonide.
Acta Derm Venereol, 75 (1995), pp. 57-58
[16.]
D.S. Owen.
Aspiration and injection of joint and soft tissues.
Textbook of Rheumatology (5.a ed.), pp. 591-608
[17.]
N.L. Gottlieb, W.G. Riskin.
Complications of local corticosteroid injections.
JAMA, 243 (1980), pp. 1547-1548
[18.]
H.I. Huppertz, H. Pfüller.
Transient suppression of endogenous cortisol production after intra-articular steroid therapy for knee synovitis.
Br J Rheumatol, 33 (1994), pp. 464-468
[19.]
A.T. Slotkoff, D.J. Clauw, D.J. Nashel.
Effects of soft tissue corticosteoid injection on glucose control in diabetes.
Arthritis Rheum, 34 (1994), pp. 347
[20.]
P. Seror, Pluvinage, F. Leqcoq d’Adre, P. Benamou, G. Attuil.
Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France).
Rheumatology, 38 (1999), pp. 1272-1274
[21.]
B. Pal, J. Morris.
Perceived risks of joint infection following intra-articular corticosteroid injections: a survey of rheumatologists.
Clin Rheumatol, 18 (1999), pp. 264-265
[22.]
B.G. Yangco, B.F. Germain, S.C. Deresinski.
Case report. Fatal gas gangrene following intra-articular steroid injection.
Am J Med Sci, 283 (1982), pp. 94-98
[23.]
G. Stutz, M.S. Kuster, F. Kleinstuck, A. Gachter.
Arthroscopic management of septic arthritis: stages of infection and results.
Knee Surg Sports Traumatol Arthrosc, 8 (2000), pp. 270-274
[24.]
D.A. Fisher.
Local anesthesia in dermatologic surgery.
J Am Acad Dermatol, 22 (1990), pp. 139-140
[25.]
R.A. Kidmore, J.D. Patterson, R.S. Tomsick.
Local anesthetics.
Dermatol Surg, 22 (1996), pp. 511-522
[26.]
J. Puyana, J. Cuesta, E. Losada.
Alergia a fármacos del grupo para-amino. En: Sociedad Española de Alergología e Inmunología Clínica, editores. Alergología Clínica (V).
pp. 247-263
[27.]
S. Mace, P. Vadas, W. Pruzanski.
Anaphylactic shock induced by intra-articular injection of methylprednisolone acetate.
J Rheumatol, 24 (1997), pp. 1191-2119
[28.]
R.G. Gray, J. Tenenbaum, N.L. Gottlieb.
Local corticosteroid injection treament in rheumatic disorders.
Semin Arthritis Rheum, 10 (1981), pp. 231-254
[29.]
M.T. Read.
Safe relief of rest pain that eases with activity in achillodynia by intrabursal or peritendinous steroid injection: the rupture rate was not increased by these steroid injections.
Br J Sports Med, 33 (1999), pp. 134-135
[30.]
R.G. Gray, I.M. Kiem, N.L. Gottlieb.
Intratendon sheath corticosteroid treatment of rheumatoid arthritis-associated and idiopathic hand flexor tenosynovitis.
Arthritis Rheum, 21 (1978), pp. 92-96
[31.]
F. Behrens, N. Shepard, N. Mitchell.
Metabolic recovery of articular cartilage after intra-articular injection of glucocorticoid.
J Bone Joint Surg, 58 (1976), pp. 1157-1160
[32.]
J.M. Williams, K.D. Brandt.
Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage.
Arthritis Rheum, 28 (1985), pp. 1267-1274
[33.]
H.W. Balch, J.M.C. Gibson, A.F. El-Ghobarey, L.S. Bain, M.P. Lynch.
Repeated corticosteroid injections into knee joints.
Rheumatol Rehab, 16 (1977), pp. 137-140
[34.]
P.D. Utsinger, D. Resnick, R.F. Shapiro, K.B. Wiesner.
Roentgenologic, immunologic, and therapeutic study of erosive (inflammatory) osteoarthritis.
Arch Intern Med, 138 (1978), pp. 693-697
[35.]
R.D. Emkey, R. Lindsay, J. Lissy.
The systemic effect of intra-articular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis.
Arthritis Rheum, 39 (1996), pp. 277-282
[36.]
M. Ostergaard, P. Halberg.
Intra-articular glucocorticoid injections in joint diseases.
Ugeskr Laeger, 161 (1999), pp. 582-586
[37.]
V. Gilsanz, B.H. Bernstein.
Joint calcification following intra-articular corticosteroid therapy.
Radiology, 151 (1984), pp. 647-649
[38.]
M.K. Dalinka, V. Stewart, J.S. Bomalaski, M. Halpern, M.E. Kricun.
Periarticular calcifications in association with intra-articular corticosteroid injections.
Radiology, 153 (1984), pp. 615-618
[39.]
J. Thumboo, J.D. O'Duffy.
A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium.
[40.]
B. Mazieres, A.M. Masquelier, M.H. Capron.
A French controlled multicenter study of intra-articular orgotein versus intra-articular corticosteroids in the treatment of knee osteoarthritis: a one year followup.
J Rheumatol, 27 (1991), pp. 134-137
[41.]
W. Gammer, L.G. Broback.
Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthrosis of the knee joint.
Scand J Rheumatol, 13 (1984), pp. 108-112
[42.]
J. Bueno, J.D. Cañete, A. Collado, J. Muñoz, X. Rabasseda, D. Romero.
Inflamación y radicales libres.
Drugs of Today, 29 (1993), pp. 1-42
[43.]
A. Joral, T. Boyano, J. Mira, J.L. Agudo, F. Saiz.
Systemic anaphylaxis following parental orgotein administration.
J Investig Allergol Clin Immunol, 3 (1993), pp. 103-104
[44.]
P.J. Barnes, I. Adcock.
Antiinflammatory actions of steroids: molecular mechanisms.
Trends Pharmacol Sci, 14 (1993), pp. 436-441
[45.]
R.P. Kimberly.
Glucocorticoids.
Curr Opin Rheumatol, 6 (1994), pp. 273-280
[46.]
G.S. Firestein, M.M. Paine, B.H. Littman.
Gene expression (collagenase, tissue inhibitor of metallopreteinases, complement, and HLADR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intra-articular corticosteroids.
Arthritis Rheum, 34 (1991), pp. 1094-1105
[47.]
J.P. Pelletier, J.A. DiBattista, J.P. Raynauld, S. Wilhelm, J. MartelPelletier.
The in vivo effects of intra-articular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
Lab Invest, 72 (1995), pp. 578-586
[48.]
F. Kantrowitz, D.R. Robinson, M.B. Mcguire.
Corticosteroids inhibit prostaglandin production by rheumatoid synovia.
Nature (Lond), 258 (1975), pp. 737-739
[49.]
E.J. Goetzl, N.E. Blanco, J.S. Alpert, C.B. Sledge, P.H. Schur.
Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis.
Ann Rheum Dis, 33 (1974), pp. 62-66
[50.]
M.J. Eymontt, G.V. Gordon, H.R. Schumacher, J.R. Hansell.
The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intra-articular corticosteroid administration.
J Rheumatol, 9 (1982), pp. 198-203
[51.]
R. Luukkainen, M. Hakala, E. Sajanti, H. Huhtala, U. Yli-Kerttula, R. Hameenkorpi.
Predictive value of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injections in patients with rheumatoid arthritis.
Ann Rheum Dis, 51 (1992), pp. 874-876
[52.]
P.P. Youssef, D.R. Haynes, S. Triantafillou, A. Parker, J.R. Gamble, P.J. Roberts-Thomson, et al.
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis.
[53.]
Z.Y. Gu, H.L. Wu, Q.L. Wu, Z.Q. Cao, Y.X. Zhang.
The effect of intra-articular irrigation injection therapy on osteoarthrosis of the temporomandibular joint.
Chin J Dent Res, 1 (1998), pp. 44-48
[54.]
L.M. Centeno, M.E. Moore.
Preferred intra-articular corticosteroids and associated practice: A survey of members of the American College of Rheumatology.
Arthritis Care Res, 7 (1994), pp. 151-155
[55.]
J.R. Caldwell.
Intra-articular corticosteroids. Guide to selection and indications for use.
Drugs, 52 (1996), pp. 507-514
[56.]
H. Derendorf, H. Mollmann, G. Voortman, F.A. Van den Ouweland, L.B. Van de Putte, G. Gevers, et al.
Pharmacokinetics of rimexolone after intra-articular administration.
J Clin Pharmacol, 30 (1990), pp. 476-479
[57.]
G. Gevers, J. Dequeker, M. Van Holsbeeck, E. Van VlietDaskalopoulou.
A high dose (up to 200 mg) tolerance and efficacy study of intra-articular rimexolone (erg 6216) in rheumatoid synovitis of the knee.
Clin Rheumatol, 13 (1994), pp. 103-109
[58.]
T. Blyth, J.A. Hunter, A. Stirling.
Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide.
Br J Rheumatol, 33 (1994), pp. 461-463
[59.]
P. Geborek, B. Mansson, F.A. Wollhelm, U. Moritz.
Intra-articular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength.
Rheumatol Int, 9 (1990), pp. 265-270
[60.]
E.J. Valtonen.
Clinical comparison of triamcinolone hexacetonide and betamethasone in the treatment of osteoarthrosis of the kneejoint.
Stand J Rheumatol, 41 (1981), pp. 3-7
[61.]
P.A. Dieppe, B. Sathapatayovongs, H.E. Jones, P.A. Baton, E.F.J. Ring.
Intra-articular steroids in osteoarthritis.
Rheumatol Rehab, 19 (1980), pp. 212-217
[62.]
R.A. Gatter.
Arthrocentesis technique and intrasynovial therapy.
Arthritis and allied conditions (11.a ed.), pp. 646-656
[63.]
A. Srinivasan, M. Amos, M. Webley.
The effects of joint washout and steroid injection compared with either joint washout or steroid injection alone in rheumathoid knee effusion.
Br J Rheumatol, 34 (1995), pp. 771-773
[64.]
P. Ravaud, L. Moulinier, B. Giraudeau, X. Ayral, C. Guerin, E. Noel, et al.
Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial.
[65.]
K. Chakravarty, P.D. Pharoah, D.G. Scott.
A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis.
Br J Rheumatol, 33 (1994), pp. 464-468
[66.]
D.J. McCarty, J.G. Harman, J.L. Grassanovich, C. Qian.
Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide.
J Rheumatol, 22 (1995), pp. 1631-1635
[67.]
R.W. Ike.
Therapeutic Injections of joints and soft tissues.
Primer on the Rheumatic Diseases (11.a ed.),
[68.]
W. Chatham, G. Williams, L. Moreland, J.W. Parker, C. Ross, S.G. Alarcón, et al.
Intra-articular corticosteroid injections: should we rest the joints?.
Arthritis Care Res, 2 (1989), pp. 70-74
Copyright © 2001. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos